+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Adrenal Corticosteroid Inhibitors Market Research Report by Treatment Type, Drug, End-user, Distribution Channel, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 147 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5313743
UP TO OFF until Dec 31st 2022
The United States Adrenal Corticosteroid Inhibitors Market size was estimated at USD 405.40 million in 2021, USD 474.80 million in 2022, and is projected to grow at a CAGR of 13.45% to reach USD 864.83 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Adrenal Corticosteroid Inhibitors to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment Type, the market was studied across Breast Cancer, Cushing's Syndrome, and Prostate Cancer.
  • Based on Drug, the market was studied across Metyrapone and Osilodrostat.
  • Based on End-user, the market was studied across Homecare, Hospitals, and Speciality Centres.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Adrenal Corticosteroid Inhibitors market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Adrenal Corticosteroid Inhibitors Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Adrenal Corticosteroid Inhibitors Market, including ChemGenix Laboratories Pvt Ltd., Ciba Pharmaceutical Company, Crinetics Pharmaceuticals, Inc., GNH India Pharmaceuticals Limited, HRA Pharma, Merck KGaA, Novartis AG, Parchem fine & specialty chemicals, Recordati S.P.A, Shenzhen Hupharma Industry Co., Ltd, and Tocris Bioscience.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Adrenal Corticosteroid Inhibitors Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Adrenal Corticosteroid Inhibitors Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Adrenal Corticosteroid Inhibitors Market?
4. What is the competitive strategic window for opportunities in the United States Adrenal Corticosteroid Inhibitors Market?
5. What are the technology trends and regulatory frameworks in the United States Adrenal Corticosteroid Inhibitors Market?
6. What is the market share of the leading vendors in the United States Adrenal Corticosteroid Inhibitors Market?
7. What modes and strategic moves are considered suitable for entering the United States Adrenal Corticosteroid Inhibitors Market?
Frequently Asked Questions about the U.S. Adrenal Corticosteroid Inhibitors Market

What is the estimated value of the U.S. Adrenal Corticosteroid Inhibitors Market?

The U.S. Adrenal Corticosteroid Inhibitors Market was estimated to be valued at $405.4 Million in 2021.

What is the growth rate of the U.S. Adrenal Corticosteroid Inhibitors Market?

The growth rate of the U.S. Adrenal Corticosteroid Inhibitors Market is 13.4%, with an estimated value of $864.83 Million by 2027.

What is the forecasted size of the U.S. Adrenal Corticosteroid Inhibitors Market?

The U.S. Adrenal Corticosteroid Inhibitors Market is estimated to be worth $864.83 Million by 2027.

Who are the key companies in the U.S. Adrenal Corticosteroid Inhibitors Market?

Key companies in the U.S. Adrenal Corticosteroid Inhibitors Market include ChemGenix Laboratories Pvt Ltd., Ciba Pharmaceutical Company, Crinetics Pharmaceuticals, Inc., GNH India Pharmaceuticals Limited, HRA Pharma, Merck KGaA, Novartis AG, Parchem fine & specialty chemicals and Shenzhen Hupharma Industry Co., Ltd.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Adrenal Corticosteroid Inhibitors Market, by Treatment Type
6.1. Introduction
6.2. Breast Cancer
6.3. Cushing's Syndrome
6.4. Prostate Cancer
7. Adrenal Corticosteroid Inhibitors Market, by Drug
7.1. Introduction
7.2. Metyrapone
7.3. Osilodrostat
8. Adrenal Corticosteroid Inhibitors Market, by End-user
8.1. Introduction
8.2. Homecare
8.3. Hospitals
8.4. Speciality Centres
9. Adrenal Corticosteroid Inhibitors Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. California Adrenal Corticosteroid Inhibitors Market
10.1. Introduction
11. Florida Adrenal Corticosteroid Inhibitors Market
11.1. Introduction
12. Illinois Adrenal Corticosteroid Inhibitors Market
12.1. Introduction
13. New York Adrenal Corticosteroid Inhibitors Market
13.1. Introduction
14. Ohio Adrenal Corticosteroid Inhibitors Market
14.1. Introduction
15. Pennsylvania Adrenal Corticosteroid Inhibitors Market
15.1. Introduction
16. Texas Adrenal Corticosteroid Inhibitors Market
16.1. Introduction
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. ChemGenix Laboratories Pvt Ltd.
18.1.1. Business Overview
18.1.2. Key Executives
18.1.3. Product & Services
18.2. Ciba Pharmaceutical Company
18.2.1. Business Overview
18.2.2. Key Executives
18.2.3. Product & Services
18.3. Crinetics Pharmaceuticals, Inc.
18.3.1. Business Overview
18.3.2. Key Executives
18.3.3. Product & Services
18.4. GNH India Pharmaceuticals Limited
18.4.1. Business Overview
18.4.2. Key Executives
18.4.3. Product & Services
18.5. HRA Pharma
18.5.1. Business Overview
18.5.2. Key Executives
18.5.3. Product & Services
18.6. Merck KGaA
18.6.1. Business Overview
18.6.2. Key Executives
18.6.3. Product & Services
18.7. Novartis AG
18.7.1. Business Overview
18.7.2. Key Executives
18.7.3. Product & Services
18.8. Parchem fine & specialty chemicals
18.8.1. Business Overview
18.8.2. Key Executives
18.8.3. Product & Services
18.9. Recordati S.P.A
18.9.1. Business Overview
18.9.2. Key Executives
18.9.3. Product & Services
18.10. Shenzhen Hupharma Industry Co., Ltd
18.10.1. Business Overview
18.10.2. Key Executives
18.10.3. Product & Services
18.11. Tocris Bioscience
18.11.1. Business Overview
18.11.2. Key Executives
18.11.3. Product & Services
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET DYNAMICS
FIGURE 8. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT TYPE, 2027
FIGURE 11. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY BREAST CANCER, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY CUSHING'S SYNDROME, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY PROSTATE CANCER, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2021 VS 2027 (%)
FIGURE 15. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2021 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG, 2027
FIGURE 17. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY METYRAPONE, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY OSILODROSTAT, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 20. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 22. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SPECIALITY CENTRES, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 26. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2027
FIGURE 28. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
FIGURE 30. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 31. CALIFORNIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. FLORIDA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. ILLINOIS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. NEW YORK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. OHIO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. PENNSYLVANIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. TEXAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 39. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 40. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY BREAST CANCER, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY BREAST CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY CUSHING'S SYNDROME, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY CUSHING'S SYNDROME, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY PROSTATE CANCER, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY PROSTATE CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY METYRAPONE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY METYRAPONE, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY OSILODROSTAT, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY OSILODROSTAT, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOMECARE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOMECARE, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SPECIALITY CENTRES, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SPECIALITY CENTRES, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 31. CALIFORNIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. CALIFORNIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 33. CALIFORNIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 34. CALIFORNIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 35. CALIFORNIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 36. FLORIDA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. FLORIDA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 38. FLORIDA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 39. FLORIDA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 40. FLORIDA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 41. ILLINOIS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 42. ILLINOIS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 43. ILLINOIS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 44. ILLINOIS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 45. ILLINOIS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 46. NEW YORK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. NEW YORK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 48. NEW YORK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 49. NEW YORK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 50. NEW YORK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 51. OHIO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 52. OHIO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 53. OHIO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 54. OHIO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 55. OHIO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 56. PENNSYLVANIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 57. PENNSYLVANIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 58. PENNSYLVANIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 59. PENNSYLVANIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 60. PENNSYLVANIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 61. TEXAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 62. TEXAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 63. TEXAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DRUG, 2018-2027 (USD MILLION)
TABLE 64. TEXAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 65. TEXAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 66. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 67. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 68. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 69. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 70. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 71. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET MERGER & ACQUISITION
TABLE 72. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 73. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 74. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET INVESTMENT & FUNDING
TABLE 75. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 76. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET: LICENSE & PRICING

Samples

Loading
LOADING...

Companies Mentioned

  • ChemGenix Laboratories Pvt Ltd.
  • Ciba Pharmaceutical Company
  • Crinetics Pharmaceuticals, Inc.
  • GNH India Pharmaceuticals Limited
  • HRA Pharma
  • Merck KGaA
  • Novartis AG
  • Parchem fine & specialty chemicals
  • Recordati S.P.A
  • Shenzhen Hupharma Industry Co., Ltd
  • Tocris Bioscience

Methodology

Loading
LOADING...